Paul Tudor Jones Gilead Sciences, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 162,373 shares of GILD stock, worth $16.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
162,373
Previous 45,200
259.23%
Holding current value
$16.9 Million
Previous $3.79 Million
295.93%
% of portfolio
0.06%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding GILD
# of Institutions
2,082Shares Held
1.02BCall Options Held
8.81MPut Options Held
9.7M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...